These findings confirm that PRCC‐TFE3 regulation in our data aligns with previously identified results in TFE3‐RCC (Figure S1; Sun et al. 2021; Funasaki et al. 2022; Prakasam et al. 2024). The gene discussed is TFE3; the disease is renal cell carcinoma.